Stock A207940 SAMSUNG BIOLOGICS CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Samsung Biologics Co.,Ltd.

Equities

A207940

KR7207940008

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
770,000 KRW -1.28% Intraday chart for Samsung Biologics Co.,Ltd. -2.53% +1.32%
Apr. 25 Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe MT
Apr. 25 Samsung Biologics Posts Higher Q1 Profit, Sales MT

Evolution of the average Target Price on Samsung Biologics Co.,Ltd.

Price target over the last 5 years

History of analyst recommendation changes

96ced2f6bddb41a227d1daa3f5.WZQk3SZfFpmGnacNh63OQgg2up-VnCLNpQlwpLYEtA8.Cv5d6386Zano6f1O8ui6CTBxitOi5U-u0EIx3Ok0-ksazWmUZDFStNXK1A~b27d7b0e76e442ef3594432e36b684fd

Analyst Recommendations on Samsung Biologics Co.,Ltd.

South Korean Shares Decline on Concerns Over China Economic Slowdown, US Fed Rate Hike MT
South Korean Shares Close Higher Ahead of US Fed's Rate Decision; Samsung Biologics Adds 2% MT
South Korean shares track Wall Street higher; Fed rate decision in focus RE
South Korea's Kospi, Kosdaq Tumble on Recession Concerns Amid Fed Rate Hike Possibility; Samsung Biologics Loses 1% MT
Samsung Biologics Earns Gold Rating from EcoVadis for Its Sustainability Efforts AQ
UBS Starts Samsung Biologics at Buy With 1,070,000 Won Price Target MT
South Korean Stocks Rise for Second Day as Investors Speculate Fed Rate Hike Pace; Samsung Bio Stock Falls 3% MT
South Korea’s Leading Index Kospi Slips on Fears over Rate Hikes Across Economies; SK Hynix Loses 2% MT
South Korean Stocks Fall for Second Day as Bank of Korea Raises Base Rate; Samsung Biologics Loses Nearly 2% MT
Samsung Electronics : S.Korea stocks end at record high as U.S. jobs data shock eases rate woes RE
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
770,000 KRW
Average target price
1,032,273 KRW
Spread / Average Target
+34.06%
High Price Target
1,250,000 KRW
Spread / Highest target
+62.34%
Low Price Target
780,000 KRW
Spread / Lowest Target
+1.30%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Samsung Biologics Co.,Ltd.

UBS

Ratings for Samsung Biologics Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. A207940 Stock
  4. Consensus Samsung Biologics Co.,Ltd.